ListarGI- GRINCAR - Artigos por tema "Diastolic dysfunction"
Mostrando ítems 1-3 de 3
-
Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors
(AlphaMed Press, 2015-07-16)[Abstract] INTRODUCTION: Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data from longitudinal studies of diastolic dysfunction (DD) in this group ... -
Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors
(Elsevier, 2023-04-18)[Abstract] Introduction. Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data on longitudinal studies about early and late onset cardiotoxicity in this ... -
Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease
(Springer, 2016)[Abstract] There are multiple intrinsic mechanisms for diastolic dysfunction ranging from molecular to structural derangements in ventricular myocardium. The molecular mechanisms regulating the progression from normal ...